Citation Impact
Citing Papers
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Mechanisms of Thrombus Formation
2008 Standout
Functionality map analysis of the active site cleft of human thrombin
1996 StandoutNobel
Selective Depletion of Low-Density CD8 + , CD16 + Lymphocytes During HIV Infection
1988 StandoutNobel
von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic Syndrome
1998 Standout
Antiphospholipid Thrombosis: Clinical Course after the First Thrombotic Event in 70 Patients
1992
Tissue factor pathway inhibitor and the revised hypothesis of blood coagulation
1992
The molecular basis of blood coagulation
1988 Standout
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system?
1990
Principal components analysis corrects for stratification in genome-wide association studies
2006 Standout
The coagulation cascade: initiation, maintenance, and regulation
1991 Standout
The Human Hypoxia-Inducible Factor 1α Gene:HIF1AStructure and Evolutionary Conservation
1998 StandoutNobel
Mutation in blood coagulation factor V associated with resistance to activated protein C
1994 StandoutNature
The Antiphospholipid Syndrome
2002 Standout
Influence of microbial infections on the progression of HIV disease
1997 StandoutNobel
Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders
1990
Resistance to Activated Protein C as a Basis for Venous Thrombosis
1994 Standout
Selective loss of the CD4+/CD26+ T-cell subset during HIV infection
1996 StandoutNobel
von Willebrand's disease
1992
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
2001 Standout
Disappearance of Hepatitis C Virus RNA in Plasma during Interferon Alpha-2B Treatment in Hemophilia Patients
1992 StandoutNobel
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Dosing with recombinant factor viia based on current evidence
2004
Tissue factor as a tumor procoagulant
1992
A Critical Evaluation of the Prothrombin Time for Monitoring Oral Anticoagulant Therapy
2003 StandoutNobel
Orphan Nuclear Receptor HNF-4 Binds to the Human Coagulation Factor VII Promoter
1995
The Pharmacology and Management of the Vitamin K Antagonists
2004 Standout
Transcriptional regulation of gene expression: Mechanisms and pathophysiology
1994 StandoutNobel
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
The Impact of Cirrhosis on CD4+ T Cell Counts in HIV-Seronegative Patients
2007
T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study
1989
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Endogenous thrombin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle
2013 StandoutNobel
Initiation of blood coagulation: the tissue factor/factor VIIa complex
1996
Thrombosis of the Cerebral Veins and Sinuses
2005 Standout
Delivery of erythropoietin by encapsulated myoblasts in a genetic model of severe anemia
2002 StandoutNobel
Coagulation activities of plasma microparticles
1988
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
Hepatitis C antibody and chronic liver disease in haemophilia
1990 StandoutNobel
BIOCHEMISTRY AND GENETICS OF VON WILLEBRAND FACTOR
1998 Standout
T-cytotoxic/suppressor cell phenotypes in a group of asymptomatic homosexual men with and without exposure to
1986
Von Willebrand Disease: A Database of Point Mutations, Insertions, and Deletions
1993
Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor.
1990
Endotoxin induced platelet microvesicle formation measured by flow cytometry
1996 StandoutNobel
Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.
1989
A Coagulation Factor IX-Deficient Mouse Model for Human Hemophilia B
1997 StandoutNobel
Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome
1989
Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation.
1977
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.
1989
Current Management of Hemophilia B
1993
Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis
1996
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections.
1994 StandoutNobel
Proteolytic Cleavage of Recombinant Type 2A von Willebrand Factor Mutants R834W and R834Q: Inhibition by Doxycycline and by Monoclonal Antibody VP-1
1997
Cerebral Venous Thrombosis and Anticardiolipin Antibodies
1997
Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
1983
Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
1990 StandoutScience
Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.
1989 Standout
Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation
1993
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism*
1999 Standout
A Cell-based Model of Hemostasis
2001 Standout
Secretory products of macrophages.
1987 Standout
Venous thrombosis: a multicausal disease
1999 Standout
Purified factor IX using monoclonal immunoaffinity technique: clinical trials in hemophilia B and comparison to prothrombin complex concentrates
1992
Hemorrhagic sequelae of immune thrombocytopenic purpura in human immunodeficiency virus-infected hemophiliacs
1990
Binding of human factor VII and VIIa to monocytes.
1982
The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects
1991
Guidelines for the management of hemophilia
2012 Standout
Contribution of Factor VII Genotype to Activated FVII Levels
1997
WFH Guidelines for the Management of Hemophilia, 3rd edition
2020 Standout
Variations in Coagulation Factors in Women: Effects of Age, Ethnicity, Menstrual Cycle and Combined Oral Contraceptive
1999
Works of CK Kasper being referenced
Distinctive lymphocyte subpopulation abnormalities in patients with congenital coagulation disorders who exhibit lymph node enlargement
1985
The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors
1986
Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion
1979
Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype
1986
The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors
1986
Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia
1985
Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype)
1989
Hemophilia B: characterization of genetic variants and detection of carriers
1977
Lupus anticoagulants: improved diagnosis with a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations
1986
Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion
1979
Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia
1985